Learn to Quit-HIV Pilot Study

Early-phase Studies of a Tailored Evidence-Based Smoking Cessation mHealth App for Persons Living With HIV

The study team will conduct a feasibility, acceptability, and preliminary efficacy trial comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only (NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and ongoing HIV clinical care.

Inclusion Criteria:

• HIV-positive
• Currently engaged with an HIV care provider
• Self-report smoking 5 cigarettes or more per day during the past 30 days
• Age 18 years or older
• Current interest in quitting smoking
• Currently own a functioning Android or Apple smartphone

Exclusion Criteria:

• No desire to quit smoking
• Inability to attend study sessions
• Inability to provide informed consent
• Any medical condition or concomitant medication that could compromise subject safety or treatment, as determined by the Principal Investigators and/or Study Physician
• Presence of contraindications for nicotine patch
• Previous allergic reaction or hypersensitivity to nicotine patch (lifetime)
• Current use of nicotine replacement therapy or other smoking cessation treatment (e.g., bupropion, varenicline)
• Pregnant, planning to become pregnant, nursing, or becoming pregnant during the study
• Current untreated and unstable diagnosis of alcohol/substance abuse or dependence (eligible if past abuse/dependence and if receiving treatment and stable for >30 days)